Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1799 1
1852 1
1945 1
1950 1
1951 3
1953 2
1954 2
1955 1
1956 2
1957 2
1958 1
1960 3
1961 1
1962 5
1963 8
1964 9
1965 5
1966 6
1967 4
1968 10
1969 8
1970 8
1971 5
1972 6
1973 9
1974 9
1975 17
1976 9
1977 12
1978 12
1979 12
1980 11
1981 16
1982 13
1983 20
1984 29
1985 29
1986 31
1987 41
1988 37
1989 51
1990 52
1991 66
1992 64
1993 57
1994 60
1995 71
1996 87
1997 87
1998 96
1999 142
2000 194
2001 254
2002 267
2003 339
2004 395
2005 471
2006 573
2007 624
2008 651
2009 768
2010 814
2011 1078
2012 1114
2013 1245
2014 1480
2015 1716
2016 1789
2017 1829
2018 2053
2019 2364
2020 2574
2021 2934
2022 2845
2023 2848
2024 3113
2025 1190

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,647 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Jaechoon
Page 1
Did you mean jaehoon jo (3 results)?
Introduction.
Jo V. Jo V. Semin Diagn Pathol. 2019 Mar;36(2):83-84. doi: 10.1053/j.semdp.2019.02.002. Epub 2019 Feb 28. Semin Diagn Pathol. 2019. PMID: 30852047 No abstract available.
Jo vs Cancer.
Ashley-Norman P. Ashley-Norman P. Lancet Gastroenterol Hepatol. 2023 Apr;8(4):306. doi: 10.1016/S2468-1253(23)00036-5. Lancet Gastroenterol Hepatol. 2023. PMID: 36905939 No abstract available.
Anti-Jo-1 antibodies.
Zampieri S, Ghirardello A, Iaccarino L, Tarricone E, Gambari PF, Doria A. Zampieri S, et al. Autoimmunity. 2005 Feb;38(1):73-8. doi: 10.1080/08916930400022640. Autoimmunity. 2005. PMID: 15804708 Free article.
Anti-Jo-1 antibody is a myositis specific autoantibody most commonly found in patients with idiopathic inflammatory myopathies (IIM). ...Moreover, anti-Jo-1 serum levels strongly correlate with disease activity representing a good marker for disease monitoring....
Anti-Jo-1 antibody is a myositis specific autoantibody most commonly found in patients with idiopathic inflammatory myopathies (IIM). …
[Antisynthetase syndromes].
Bauhammer J, Fiehn C. Bauhammer J, et al. Z Rheumatol. 2019 Sep;78(7):645-655. doi: 10.1007/s00393-019-0665-0. Z Rheumatol. 2019. PMID: 31346706 Review. German.
Autoantibodies to 11 aminoacyl-tRNA synthetases are known of which 8 have so far been associated with the clinical manifestation of ASS. The Jo-1 antibody is by far the most frequent one. The antibodies differ in the rate and severity of the main and accompanying symptoms. …
Autoantibodies to 11 aminoacyl-tRNA synthetases are known of which 8 have so far been associated with the clinical manifestation of ASS. The …
Clinical spectrum of anti-Jo-1-associated disease.
Monti S, Montecucco C, Cavagna L. Monti S, et al. Curr Opin Rheumatol. 2017 Nov;29(6):612-617. doi: 10.1097/BOR.0000000000000434. Curr Opin Rheumatol. 2017. PMID: 28796005 Review.
PURPOSE OF REVIEW: To provide the most recent evidence on anti-Jo-1 syndrome. RECENT FINDINGS: Several new evidences on anti-Jo-1 syndrome have recently emerged. ...SUMMARY: Recent evidence has shed a light on the need for a better understanding of the clinical cour …
PURPOSE OF REVIEW: To provide the most recent evidence on anti-Jo-1 syndrome. RECENT FINDINGS: Several new evidences on anti-Jo
Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.
Ascherman DP. Ascherman DP. Curr Rheumatol Rep. 2015 Sep;17(9):56. doi: 10.1007/s11926-015-0532-1. Curr Rheumatol Rep. 2015. PMID: 26210509 Review.
Histidyl-tRNA synthetase (HRS = Jo-1) represents a key autoantibody target in the anti-synthetase syndrome that is marked by myositis as well as extra-muscular organ complications including interstitial lung disease (ILD). ...Combining these facets of Jo-1-mediated …
Histidyl-tRNA synthetase (HRS = Jo-1) represents a key autoantibody target in the anti-synthetase syndrome that is marked by myositis …
COVID-19 vaccination-associated anti-Jo-1 syndrome.
Gupta K, Sharma GS, Kumar A. Gupta K, et al. Reumatologia. 2021;59(6):420-422. doi: 10.5114/reum.2021.111836. Epub 2021 Dec 14. Reumatologia. 2021. PMID: 35079187 Free PMC article.
The patient was further found to be positive for anti-Jo-1 antibody. The initial treatment was glucocorticosteroids and methotrexate initially. ...The treatment was switched to mycophenolate mofetil with good response. We presented the first case of anti-Jo-1 syndro …
The patient was further found to be positive for anti-Jo-1 antibody. The initial treatment was glucocorticosteroids and methotrexate …
Changbum Jo.
[No authors listed] [No authors listed] Angew Chem Int Ed Engl. 2023 Jul 24;62(30):e202306801. doi: 10.1002/anie.202306801. Epub 2023 Jun 23. Angew Chem Int Ed Engl. 2023. PMID: 37350120
"The most exciting thing about my research is the process of designing organic molecules to synthesize inorganic nanostructures in a manner that meets our objectives The most important thing I have learned from my students is that the benchmark for giving one's best varies from p …
"The most exciting thing about my research is the process of designing organic molecules to synthesize inorganic nanostructures in a manner …
Anti-Jo-1 antisynthetase syndrome.
Shinjo SK, Levy-Neto M. Shinjo SK, et al. Rev Bras Reumatol. 2010 Sep-Oct;50(5):492-500. doi: 10.1590/s0482-50042010000500003. Rev Bras Reumatol. 2010. PMID: 21125186 English, Portuguese.
OBJECTIVE: Given a lack of population-based studies, we report an epidemiological-clinic study of anti-Jo-1 antisynthetase syndrome (ASS). PATIENTS AND METHODS: To study a retrospective cohort of a single-center from 1980 to 2010. ...All patients fulfilled the Bohan and Pe …
OBJECTIVE: Given a lack of population-based studies, we report an epidemiological-clinic study of anti-Jo-1 antisynthetase syndrome ( …
Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome.
Yang H, Chen Q, Sun C, Jin Q, Zhang L, Liu Q, Peng Q, Wang G, Lu X. Yang H, et al. Respir Res. 2024 May 29;25(1):222. doi: 10.1186/s12931-024-02851-w. Respir Res. 2024. PMID: 38811943 Free PMC article.
OBJECTIVE: To investigate the association of serum anti-Jo-1 antibody levels with the disease activity and prognosis in anti-Jo-1-positive patients with antisynthetase syndrome (ASS). ...Anti-Jo-1 antibody serum levels at initial admission and follow-up were …
OBJECTIVE: To investigate the association of serum anti-Jo-1 antibody levels with the disease activity and prognosis in anti-Jo
32,647 results
You have reached the last available page of results. Please see the User Guide for more information.